N-Acetyl Cysteine in Trichotillomania

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a 12-week, double-blind study of N-Acetyl Cysteine in the treatment of trichotillomania

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Chicago
• Treatments: Acetylcysteine; N-monoacetylcystine

Criteria

Inclusion Criteria:

• men and women age 18-65;

• current DSM-IV trichotillomania

Exclusion Criteria:

• unstable medical illness;

• history of seizures;

• myocardial infarction within 6 months;

• current pregnancy or lactation, or inadequate contraception in women of childbearing potential;

• any thoughts of suicide;

• lifetime history of DSM-IV bipolar disorder type I, dementia, or schizophrenia or any other DSM-IV psychotic disorder;

• previous treatment with N-Acetyl Cysteine;

• treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline;

• 9) diagnosis of asthma